###begin article-title 0
###xml 24 30 <span type="species:ncbi:9913">Bovine</span>
Antibacterial Effect of Bovine Lactoferrin Against Udder Pathogens
###end article-title 0
###begin p 1
###xml 71 132 71 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli (E. coli), Staphylococcus aureus (S. aureus)</italic>
###xml 191 230 191 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas aeruginosa (P. aeruginosa) </italic>
###xml 234 271 234 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae (K. pneumoniae)</italic>
###xml 699 707 699 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 841 849 841 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 853 866 853 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. aeruginosa</italic>
###xml 874 882 874 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 71 87 <span type="species:ncbi:562">Escherichia coli</span>
###xml 89 96 <span type="species:ncbi:562">E. coli</span>
###xml 99 120 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 122 131 <span type="species:ncbi:1280">S. aureus</span>
###xml 191 213 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 215 228 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 234 255 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 257 270 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 298 304 <span type="species:ncbi:9913">bovine</span>
###xml 699 706 <span type="species:ncbi:562">E. coli</span>
###xml 841 848 <span type="species:ncbi:562">E. coli</span>
###xml 853 866 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 874 881 <span type="species:ncbi:562">E. coli</span>
The antibacterial effect of lactoferrin (Lf) was tested on isolates of Escherichia coli (E. coli), Staphylococcus aureus (S. aureus), and coagulase-negative staphylococci (CNS) as well as on Pseudomonas aeruginosa (P. aeruginosa) and Klebsiella pneumoniae (K. pneumoniae), originally isolated from bovine mastitis. Concentrations of Lf used were 0.67 mg/ml, 1.67 mg/ml, and 2.67 mg/ml. Growth of udder pathogens was monitored by turbidometry either in broth culture or in whey prepared from normal milk. We focused on 3 different growth variables: lag time, slope, and maximum absorbance of bacterial growth curves. Growth inhibition was seen in the broth but hardly at all in whey. The isolates of E. coli and CNS did not grow sufficiently well in whey to draw any conclusions. The most effective inhibitory activity of Lf was seen against E. coli and P. aeruginosa. All 5 E. coli isolates had similar growth patterns. Inhibition of growth by Lf was concentration-dependent. The concentration of 0.67 mg/ml in broth and whey was generally too low for a significant inhibitory effect.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 203 211 203 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 426 530 426 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli, Staphylococcus aureus, Bacillus subtilis, Klebsiella pneumoniae, Streptococcus mutans </italic>
###xml 534 550 534 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans</italic>
###xml 566 567 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 643 652 643 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 653 654 653 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 426 442 <span type="species:ncbi:562">Escherichia coli</span>
###xml 444 465 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 467 484 <span type="species:ncbi:1423">Bacillus subtilis</span>
###xml 486 507 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 509 529 <span type="species:ncbi:1309">Streptococcus mutans</span>
###xml 534 550 <span type="species:ncbi:5476">Candida albicans</span>
Lactoferrin (Lf) is an iron-binding glycoprotein found in milk, other external secretions, and the granules of neutrophilic polymorphonuclear leukocytes [3,17,18]. Lf has been shown to be bacteriostatic in vitro, and this inhibitory activity is believed to be the result of the powerful iron-chelating ability of Lf, making iron unavailable to bacteria [22,25]. Lactoferrin has a broad-spectrum antimicrobial activity against Escherichia coli, Staphylococcus aureus, Bacillus subtilis, Klebsiella pneumoniae, Streptococcus mutans and Candida albicans, among others [2,15]. Lf has also been shown to enhance the activity of some antimicrobials in vitro [7,23].
###end p 3
###begin p 4
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Evidence from a number of studies indicates that the antimicrobial activity of Lf is more complex than simple Fe chelation. Lf has bactericidal activity and can kill susceptible bacteria by a mechanism distinct from sequestering of Fe [2,4,6,9,10] established that the antimicrobial domain is near the N-terminus of Lf in a region distinct from its iron-binding sites. Apo-Lf (iron-free Lf) was shown to increase bacterial cell membrane permeability and directly damage the outer membrane of Gram-negative bacteria [9,10].
###end p 4
###begin p 5
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 7 13 <span type="species:ncbi:9913">bovine</span>
###xml 347 351 <span type="species:ncbi:9913">cows</span>
Normal bovine milk contains low concentrations of Lf, approximately 0.1 mg/ml or less, but in dry udder secretion Lf concentration is markedly higher and can reach a level of 20 mg/ml or higher [24,26]. During the dry period, the udder is very resistant to coliform infections, mostly due to the high Lf content of the secretion [20]. In mastitic cows, Lf concentrations of the milk have been shown to increase dramatically and can range from 0.3 mg/ml to 2.3 mg/ml [11,13].
###end p 5
###begin p 6
###xml 47 48 47 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 380 388 380 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 357 363 <span type="species:ncbi:9913">bovine</span>
Lf may have therapeutic potential in mastitis [7,14]. It could partly replace the use of antimicrobials, which cause problems due to residues in milk and the risk for emergence of resistance. Studies on the in vitro susceptibility of udder pathogens to Lf are, however, scant. The aim of this study was to determine the antibacterial activity of Lf against bovine udder pathogens in vitro.
###end p 6
###begin title 7
Materials and methods
###end title 7
###begin title 8
Lactoferrin
###end title 8
###begin p 9
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 284 286 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
###xml 391 393 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 494 496 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 549 550 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 0 6 <span type="species:ncbi:9913">Bovine</span>
Bovine Lf was purified from cheese whey or concentrated cheese whey by the expanded bed absorption chromatography method [12]. Iron content of native Lf was approximately 8%-15% [12]. Lf was stored frozen at -20degreesC and sterile-filtered (32 mm Acrodisc PT Syringe Filters 0.8/0.2 mum, Gelman Laboratory REF: 4658) before use. The final concentration of Lf in the product was 35.5 mg/ml [12]. Purity of Lf was tested in SDS-page (sodium dodecyl sulphate polyacrylamide gel electrophoresis) [12]. Apo-Lf was prepared from Lf by citrate dialyzing [8], and its iron content was approximately 4%.
###end p 9
###begin title 10
Growth media
###end title 10
###begin p 11
Two growth media were used for bacterial cultures: the commercial Iso Sensitest-Broth (ISB CM473, Oxoid Ltd., Basingstoke, Hampshire, England), and whey. Whey was prepared from 3 liters of fresh raw milk obtained from the university dairy herd by high-speed centrifugation of defatted milk (32600 g for 60 min at 4degreesC). Aliquots of 40-ml whey were sterile-filtered and frozen immediately after preparation for later use.
###end p 11
###begin title 12
Bacterial isolates and the preparation of inoculums
###end title 12
###begin p 13
###xml 17 35 17 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli, S. aureus</italic>
###xml 81 83 81 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2 </italic>
###xml 95 109 95 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. aeruginosa </italic>
###xml 127 141 127 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 400 410 400 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 1052 1053 1034 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 1336 1337 1318 1319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 17 24 <span type="species:ncbi:562">E. coli</span>
###xml 26 35 <span type="species:ncbi:1280">S. aureus</span>
###xml 95 108 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 127 140 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 199 205 <span type="species:ncbi:9913">bovine</span>
###xml 400 409 <span type="species:ncbi:1280">S. aureus</span>
Five isolates of E. coli, S. aureus, and coagulase negative-staphylococci (CNS), 2 isolates of P. aeruginosa and 2 isolates of K. pneumoniae originally isolated from subclinical or clinical cases of bovine mastitis were used. These isolates were received from the mastitis laboratory of the Faculty of Veterinary Medicine and the National Veterinary and Food Research Institute, Helsinki. One of the S. aureus isolates was the reference isolate M60 kindly provided by Dr. A. J. Guidry (Immunology and Disease Resistance Laboratory USDA, Beltsville, USA). During the experiment, bacteria were maintained on blood agar plates at 8degreesC. To adapt the bacterial isolates to grow in whey, they were grown overnight at 37degreesC in a growth medium consisting of 2/3 Iso Sensitest-Broth and 1/3 sterile whey. The cultures were tested using Gram-staining for purity. Bacteria were harvested by centrifugation (5000 g for 10 min) and washed twice between centrifugations using sterile saline (0.9% NaCl, 20degreesC). A suspension containing approximately 109colony-forming units (CFU) in 0.9% NaCl was prepared according to the McFarland standard (bioMerieux sa, 69280 Marcy I'Etoile, France) by spectrophotometry (550 nm, Hitatchi U-2000, Hitachi, Ltd., Tokyo, Japan). Bacterial suspension was diluted to the final concentration of 1.5 x 103CFU/ml used in each well.
###end p 13
###begin title 14
Analysis of bacterial growth by turbidometry
###end title 14
###begin p 15
###xml 329 331 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
###xml 353 355 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
###xml 390 392 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
###xml 426 428 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
###xml 513 515 509 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
###xml 521 523 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
###xml 533 535 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
###xml 604 606 597 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
###xml 669 671 661 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
###xml 695 697 686 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
###xml 788 790 778 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#956;</italic>
###xml 1192 1200 1169 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1206 1216 1183 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 1192 1199 <span type="species:ncbi:562">E. coli</span>
###xml 1206 1215 <span type="species:ncbi:1280">S. aureus</span>
Bacterial growth was measured using turbidometry (Bioscreen instrument, Labsystems, Helsinki, Finland). The instrument is a fully automated analyzing system for measuring bacterial growth using the vertical light bath with wide band absorption principle; 200 individual samples can be run simultaneously. Each well contained 100 mul of ISB broth or 150 mul of whey as the growth medium, 50 mul of bacterial suspension, and 50 mul of Lf concentrate. Physiological saline was added to bring the final volume to 300 mul: 50 mul and 100 mul in ISB and whey wells, respectively. Tested amounts of Lf were 200 mug (the final Lf concentration in the well was 0.67 mg/ml), 500 mug (1.67 mg/ml), and 800 mug (2.67 mg/ml). Control wells contained all components except Lf, which was replaced by 50 mul of 0.9% saline. Five parallel wells were used. Wells between whey and ISB wells were filled with 0.9% NaCl to prevent cross-contamination. The wells on 2 100-well plates were covered and preincubated in the Bioscreen instrument for 30 min at 37degreesC. The change in turbidity was monitored automatically every hour for 20 h at 37degreesC. The plates were shaken 10 min before each measurement. Two E. coli and 2 S. aureus isolates were also tested with Apo-Lf. The lag time (time from beginning of incubation until the time-point when absorbance began to increase), slope (slope of the growth curve in logarithmic growth phase), and maximum absorbance (highest absorbance value measured during the 20-h period) were used as variables describing the bacterial growth. After the 20-h incubation period, bacterial survival and bactericidal effect of Lf in the wells were confirmed by culturing aliquots of 10 ml on blood agar plates and incubating the plates overnight at 37degreesC.
###end p 15
###begin title 16
Statistical methods
###end title 16
###begin p 17
The effect of different Lf concentrations on lag time, slope, and maximum absorbance was tested by repeated measures analysis of variance with concentration as a within factor. The significance of concentration was evaluated by Greenhouse-Geisser adjusted p-values. Concentrations of 0.67, 1.67, and 2.67 mg/ml of Lf were further compared with a negative control.
###end p 17
###begin title 18
Results
###end title 18
###begin p 19
###xml 46 64 46 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli, S. aureus</italic>
###xml 93 94 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 159 167 159 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 171 185 171 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. aeruginosa </italic>
###xml 247 255 247 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 361 369 361 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 447 455 447 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 576 584 576 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 46 53 <span type="species:ncbi:562">E. coli</span>
###xml 55 64 <span type="species:ncbi:1280">S. aureus</span>
###xml 159 166 <span type="species:ncbi:562">E. coli</span>
###xml 171 184 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 247 254 <span type="species:ncbi:562">E. coli</span>
###xml 361 368 <span type="species:ncbi:562">E. coli</span>
###xml 447 454 <span type="species:ncbi:562">E. coli</span>
###xml 576 583 <span type="species:ncbi:562">E. coli</span>
Results of growth inhibition by Lf in ISB for E. coli, S. aureus, and CNS are shown in Table 1. The best inhibitory activity of Lf in the ISB was seen against E. coli and P. aeruginosa (data not shown for the latter). The typical growth curves of E. coli in the ISB broth with different concentrations of Lf are shown in Fig. 1. The inhibitory effect of Lf for E. coli was concentration-dependent (Fig. 2), and variation between the 5 isolates of E. coli was small. None of the isolates was totally resistant to Lf. The effect of Lf on the maximum absorbance and the slope of E. coli in ISB was statistically significant (p = 0.025 and p < 0.001, respectively), whereas the effect on the lag time was not significant (p = 0.065).
###end p 19
###begin p 20
Effect of Lf on bacterial growth in ISB culture, measured by lag time and maximum absorbance.
###end p 20
###begin p 21
Lag time = time from the beginning of incubation until the time-point when the absorbance began to increase; maximum absorbance = highest absorbance value measured during the 20-h incubation period.
###end p 21
###begin p 22
Statistically significant difference when compared with negative control: * p </= 0.05
###end p 22
###begin p 23
###xml 17 25 17 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 17 24 <span type="species:ncbi:562">E. coli</span>
Growth curves of E. coli FT238 in Iso Sensitest-Broth (ISB) with concentrations of 0.67, 1.67, and 2.67 mg/ml lactoferrin (Lf) and without Lf.
###end p 23
###begin p 24
###xml 55 63 55 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 55 62 <span type="species:ncbi:562">E. coli</span>
Mean and SD of lag time and maximum absorbance of five E. coli isolates in ISB with concentrations of 0.67, 1.67, and 2.67 mg/ml Lf and without Lf.
###end p 24
###begin p 25
###xml 28 42 28 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. aeruginosa </italic>
###xml 101 115 101 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 162 176 162 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K. pneumoniae </italic>
###xml 28 41 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 101 114 <span type="species:ncbi:573">K. pneumoniae</span>
###xml 162 175 <span type="species:ncbi:573">K. pneumoniae</span>
The growth of 2 isolates of P. aeruginosa was clearly inhibited in ISB. In contrast, the growth of 2 K. pneumoniae isolates was hardly inhibited at all. In whey, K. pneumoniae showed variable susceptibility and the results were contradictory (data not shown).
###end p 25
###begin p 26
###xml 24 34 24 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 372 382 372 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 526 536 526 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 627 637 627 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 806 816 806 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 956 978 956 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli, P. aeruginosa</italic>
###xml 24 33 <span type="species:ncbi:1280">S. aureus</span>
###xml 74 81 <span type="species:ncbi:562">E. coli</span>
###xml 172 181 <span type="species:ncbi:1280">S. aureus</span>
###xml 372 381 <span type="species:ncbi:1280">S. aureus</span>
###xml 526 535 <span type="species:ncbi:1280">S. aureus</span>
###xml 627 636 <span type="species:ncbi:1280">S. aureus</span>
###xml 806 815 <span type="species:ncbi:1280">S. aureus</span>
###xml 956 963 <span type="species:ncbi:562">E. coli</span>
###xml 965 978 <span type="species:ncbi:287">P. aeruginosa</span>
The isolates of CNS and S. aureus in ISB showed more variation to Lf than E. coli. Lf had significant effects on lag time (p = 0.014) and maximum absorbance (p = 0.014) of S. aureus, while no significant effects were seen for CNS (Table 1). As regards the slope, a statistically significant difference was present between Lf concentration and the control in the growth of S. aureus (p = 0.001) and CNS (p = 0.002). The growth of four CNS isolates was somewhat inhibited by Lf, but one was totally resistant. Three isolates of S. aureus were more susceptible to Lf than the 2 other isolates at 0.67 mg/ml of Lf. The results for S. aureus in whey are presented in Table 2. Lf concentration had a significant inhibitory effect on lag time (p = 0.015), maximum absorbance (p = 0.011), and slope (p = 0.027) of S. aureus in whey. The initial absorbancies in whey wells were higher than in ISB cultures (~1.0) because whey is more turbid than ISB. The growth of E. coli, P. aeruginosa, and CNS isolates was so poor in normal whey that it was not possible to draw any conclusions about the effect of Lf in that medium.
###end p 26
###begin p 27
###xml 30 39 <span type="species:ncbi:1280">S. aureus</span>
Effect of Lf on the growth of S. aureus in whey culture, measured by lag time and maximum absorbance. The initial absorbancies in whey wells were higher than in ISB cultures (~1.0) because whey is more turbid than ISB. For explanations see Table 1
###end p 27
###begin p 28
- = no bacterial growth
###end p 28
###begin p 29
Statistically significant difference when compared with negative control:
###end p 29
###begin p 30
* p < 0.05 ** p < 0.01
###end p 30
###begin p 31
###xml 16 24 16 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 42 52 42 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 16 23 <span type="species:ncbi:562">E. coli</span>
###xml 42 51 <span type="species:ncbi:1280">S. aureus</span>
Two isolates of E. coli and 2 isolates of S. aureus were also tested with Apo-Lf in ISB. The results were similar to those of native Lf (data not shown).
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 39 48 39 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 173 180 173 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 293 300 293 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 411 420 411 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 447 455 447 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 890 898 890 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 902 916 902 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kl. pneumoniae</italic>
###xml 919 920 919 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1024 1032 1024 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1200 1202 1200 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 1324 1326 1324 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1406 1414 1406 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 29 35 <span type="species:ncbi:9913">bovine</span>
###xml 173 180 <span type="species:ncbi:562">E. coli</span>
###xml 293 300 <span type="species:ncbi:562">E. coli</span>
###xml 447 454 <span type="species:ncbi:562">E. coli</span>
###xml 529 535 <span type="species:ncbi:9913">bovine</span>
###xml 832 838 <span type="species:ncbi:9913">bovine</span>
###xml 890 897 <span type="species:ncbi:562">E. coli</span>
###xml 1024 1031 <span type="species:ncbi:562">E. coli</span>
###xml 1406 1413 <span type="species:ncbi:562">E. coli</span>
###xml 1436 1442 <span type="species:ncbi:9913">bovine</span>
Our results demonstrate that bovine Lf in vitro is bacteriostatic towards some udder pathogens. The most interesting finding was the clear inhibitory activity of Lf against E. coli, which is in agreement with many previous studies [8,19,21]. Unfortunately, the most important target pathogen, E. coli, was in our study unable to grow in whey prepared from bulk milk with low somatic cell count. [21] tested the in vitro susceptibility to Lf of 35 E. coli isolates, which had originally been isolated from clinical or subclinical bovine mastitis. He found that most of the isolates were completely inhibited by 0.1 mg/ml Apo-Lf at the end of the 16-h incubation period. A few isolates partially resisted the bacteriostatic action of Lf, but none was totally resistant. [19] reported bacteriostatic, but not bactericidal, activity of bovine Lf against Gram-negative mastitis-causing bacteria E. coli and Kl. pneumoniae. [8] reported that an Lf concentration of 1.0 mg/ml inhibited growth of all 19 isolates of enterotoxigenic E. coli isolated from porcine enteritis. The degree of inhibition was strain-dependent. Bacterial killing occurred at relatively high initial concentrations of bacteria (5 x 103 CFU/ml), but bacteriostatic effects were seen even at higher concentrations. Contradictory results have also been found; [23] did not see effect of Lf alone at concentrations from 0.5 to 3 mg/ml on three E. coli strains isolated from bovine mastitis.
###end p 33
###begin p 34
###xml 1 2 1 2 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 99 100 99 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 204 214 204 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 217 225 217 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 150 156 <span type="species:ncbi:9913">bovine</span>
###xml 204 213 <span type="species:ncbi:1280">S. aureus</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 245 251 <span type="species:ncbi:9913">bovine</span>
###xml 502 506 <span type="species:ncbi:9913">cows</span>
[8] found no significant differences in the activity between native (32% Fe) and Apo-(<1% Fe) Lf. [5] pointed out that Apo- and Fe-saturated forms of bovine Lf were equally effective against experimental S. aureus in in vivo infections in mice; bovine Lf with different degrees of iron saturation (9%-97%) was found to be similar. We conducted limited testing using Apo-Lf, the results being comparable with those of native Lf. However, because Apo-Lf is not a realistic candidate for potential use in cows, we focused on native Lf.
###end p 34
###begin p 35
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 100 103 <span type="species:ncbi:9913">cow</span>
###xml 137 141 <span type="species:ncbi:9913">cows</span>
###xml 248 252 <span type="species:ncbi:9913">cows</span>
We used whey as a growth medium because it simulates the environment of the milk compartment of the cow udder. Whey from milk of healthy cows is known to inhibit the growth of a number of bacterial species [16]. Whey prepared from milk of mastitic cows may have been a better medium for our studies, but it would have been difficult to standardize the medium and compare our results with those of other authors.
###end p 35
###begin p 36
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 702 703 702 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 779 789 779 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 951 952 951 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 953 955 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 970 979 970 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1023 1031 1023 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1267 1274 1267 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 1467 1475 1467 1475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 779 788 <span type="species:ncbi:1280">S. aureus</span>
###xml 1002 1007 <span type="species:ncbi:10090">mouse</span>
###xml 1023 1030 <span type="species:ncbi:562">E. coli</span>
###xml 1068 1073 <span type="species:ncbi:9606">human</span>
###xml 1267 1274 <span type="species:ncbi:562">E. coli</span>
###xml 1311 1315 <span type="species:ncbi:9913">cows</span>
The mechanism by which Lf inhibits bacterial growth has not been fully elucidated. Early studies attributed such effects to the acquisition of essential Fe from the environment, but more recent findings have implicated wider cell interactions. Lf damages the outer membrane of bacteria, with a concomitant release of LPS from Gram-negative bacteria. The ultrastuctural alterations caused by Lf to the bacteria enhance the activity of some antimicrobial agents [7,23], and one approach could be to combine Lf with antibiotics in treating infections. We decided to test Lf alone to avoid the problems related to the use antibiotics and to see the real net effect of Lf against several bacteria species. [7] demonstrated a synergistic effect between Lf and penicillin against three S. aureus strains tested. Lf alone showed a weak inhibitory activity which agrees with our results. Lf can also bind LPS and at least partly block its detrimental effects [1,27] demonstrated in vitro and in an experimental mouse model that the E. coli endotoxin-neutralizing capability of human Lf was derived from a 33-mer synthetic peptide, lactoferricin. Lf or lactoferricin could potentially be used for the treatment of endotoxin-induced septic shock. Gram-negative bacteria, mainly E. coli, cause severe mastitis in lactating cows, which may result in endotoxin shock and death. Lf could be a potentially useful treatment for this condition, but its efficacy should be tested using in vivo studies.
###end p 36
###begin title 37
Conclusion
###end title 37
###begin p 38
###xml 195 203 195 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 207 220 207 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. aeruginosa</italic>
###xml 279 287 279 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 368 378 368 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 456 465 456 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 195 202 <span type="species:ncbi:562">E. coli</span>
###xml 207 220 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 279 286 <span type="species:ncbi:562">E. coli</span>
###xml 368 377 <span type="species:ncbi:1280">S. aureus</span>
###xml 446 452 <span type="species:ncbi:9913">bovine</span>
The antibacterial effects of Lf could only be demonstrated in the ISB medium, as bacterial growth in whey was weak and variable. The best inhibitory activity of Lf was seen against Gram-negative E. coli and P. aeruginosa. The variation in the susceptibility of the 5 isolates of E. coli to Lf was small, and none of the isolates was totally resistant. The response of S. aureus and CNS isolates to Lf was more variable. Our findings confirm that bovine Lf in vitro is antibacterial towards some major pathogens.
###end p 38
###begin title 39
Acknowledgements
###end title 39
###begin p 40
We thank our cooperators Riitta Keiski, Liisa Myllykoski, Kimmo Vahtola, Carita Berg, and Paivi Anttila at the University of Oulu, Finland, who provided the Lf. We also thank Arto Ketola, M. Sc. (Soc.), for statistical analysis and Ilkka Saastamoinen (technician) and Susann Sunqvist (laboratory assistant) for their technical support.
###end p 40
###begin article-title 41
Lactoferrin is a lipid A-binding protein
###end article-title 41
###begin article-title 42
###xml 25 30 <span type="species:ncbi:9606">human</span>
Bactericidal activity of human lactoferrin: sensitivity of a variety of micro-organisms
###end article-title 42
###begin article-title 43
###xml 53 59 <span type="species:ncbi:9986">rabbit</span>
Association of lactoferrin with specific granules in rabbit heterophil leucocytes
###end article-title 43
###begin article-title 44
Identification of the bactericidal domain of lactoferrin
###end article-title 44
###begin article-title 45
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice
###end article-title 45
###begin article-title 46
Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface
###end article-title 46
###begin article-title 47
###xml 94 116 94 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus </italic>
###xml 94 115 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 130 136 <span type="species:ncbi:9913">bovine</span>
Effect of lacto-ferrin in combination with penicillin on the morphology and the physiology of Staphylococcus aureus isolated from bovine mastitis
###end article-title 47
###begin article-title 48
###xml 68 84 68 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 68 84 <span type="species:ncbi:562">Escherichia coli</span>
Forms of lactoferrin: their antibacterial effect on enterotoxigenic Escherichia coli
###end article-title 48
###begin article-title 49
Damage of outer membrane of enteric gram negative bacteria by lactoferrin and transferrin
###end article-title 49
###begin article-title 50
###xml 88 91 88 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 97 99 97 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Lactoferrin and transferrin damage of the gram negative outer membare is modulated by Ca2+ and Mg2+
###end article-title 50
###begin article-title 51
###xml 42 48 <span type="species:ncbi:9913">bovine</span>
###xml 145 149 <span type="species:ncbi:9913">cows</span>
Changes in lactoferrin, immunoglubulin G, bovine serum albumin, and alpha lactalbumin during acute experimental and natural coliform mastitis of cows
###end article-title 51
###begin article-title 52
###xml 61 67 <span type="species:ncbi:9913">bovine</span>
Separation of whey antimicrobial proteins and development of bovine lactoferrin immunoassays
###end article-title 52
###begin article-title 53
###xml 37 43 <span type="species:ncbi:9913">bovine</span>
Lactoferrin concentration in milk of bovine clinical mastitis
###end article-title 53
###begin article-title 54
###xml 76 83 <span type="species:ncbi:562">E. coli</span>
Effect of lactoferrin and cephapirin, alone and in combination on growth of E. coli strains from mastitis
###end article-title 54
###begin article-title 55
Lactoferrin: molecular structure and biological function
###end article-title 55
###begin article-title 56
Mastitis whey - a good medium for bacteria?
###end article-title 56
###begin article-title 57
An iron-binding protein common to many external secretions
###end article-title 57
###begin article-title 58
Lactoferrin, an iron-binding protein in neutrophilic leucocytes
###end article-title 58
###begin article-title 59
###xml 35 41 <span type="species:ncbi:9913">bovine</span>
Inhibition of mastitic bacteria by bovine milk apo-lactoferrin evaluated by in vitro microassay of bacterial growth
###end article-title 59
###begin article-title 60
###xml 21 38 21 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 42 64 42 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Klebsiella pneumoniae </italic>
###xml 21 37 <span type="species:ncbi:562">Escherichia coli</span>
###xml 42 63 <span type="species:ncbi:573">Klebsiella pneumoniae</span>
###xml 89 95 <span type="species:ncbi:9913">bovine</span>
Growth inhibition of Escherichia coli and Klebsiella pneumoniae during involution of the bovine mammary gland: relation to secretion composition
###end article-title 60
###begin article-title 61
###xml 27 33 <span type="species:ncbi:9913">bovine</span>
Bacteriostatic activity of bovine milk lactoferrin against mastitic bacteria
###end article-title 61
###begin article-title 62
Bacterial inhibitors in milk and other biological fluids
###end article-title 62
###begin article-title 63
Enhancement of the activity of novobiocin against Escerichia coli by lactoferrin
###end article-title 63
###begin article-title 64
Biology and origin of bioactive peptides in milk
###end article-title 64
###begin article-title 65
Iron and infection
###end article-title 65
###begin article-title 66
###xml 51 57 <span type="species:ncbi:9913">bovine</span>
Lactoferrin concentration during involution of the bovine mammary gland
###end article-title 66
###begin article-title 67
###xml 54 59 <span type="species:ncbi:9606">human</span>
Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide
###end article-title 67

